Impact of TP53 Mutations on EGFR-Tyrosine Kinase Inhibitor Efficacy and Potential Treatment Strategy. Fu J, Tong Y, Xu Z, Li Y, et al. Clin Lung Cancer 2023;24:29-39.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fu J, Tong Y, Xu Z, Li Y, et al. Impact of TP53 Mutations on EGFR-Tyrosine Kinase Inhibitor Efficacy and Potential Treatment Strategy. Clin Lung Cancer 2023;24:29-39.
PMID: 36117108